vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and NexPoint Real Estate Finance, Inc. (NREF). Click either name above to swap in a different company.

NexPoint Real Estate Finance, Inc. is the larger business by last-quarter revenue ($11.1M vs $7.8M, roughly 1.4× CRYO CELL INTERNATIONAL INC). NexPoint Real Estate Finance, Inc. runs the higher net margin — 216.6% vs -48.7%, a 265.3% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -48.8%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.

CCEL vs NREF — Head-to-Head

Bigger by revenue
NREF
NREF
1.4× larger
NREF
$11.1M
$7.8M
CCEL
Growing faster (revenue YoY)
CCEL
CCEL
+46.6% gap
CCEL
-2.3%
-48.8%
NREF
Higher net margin
NREF
NREF
265.3% more per $
NREF
216.6%
-48.7%
CCEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
NREF
NREF
Revenue
$7.8M
$11.1M
Net Profit
$-3.8M
$24.0M
Gross Margin
77.9%
Operating Margin
-50.6%
Net Margin
-48.7%
216.6%
Revenue YoY
-2.3%
-48.8%
Net Profit YoY
-105.1%
58.7%
EPS (diluted)
$-0.46
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
NREF
NREF
Q4 25
$7.8M
$11.1M
Q3 25
$7.8M
$12.5M
Q2 25
$7.9M
$12.1M
Q1 25
$8.0M
$11.5M
Q4 24
$8.0M
$21.7M
Q3 24
$8.1M
$12.5M
Q2 24
$8.0M
$6.7M
Q1 24
$7.9M
$-12.8M
Net Profit
CCEL
CCEL
NREF
NREF
Q4 25
$-3.8M
$24.0M
Q3 25
$749.4K
$50.9M
Q2 25
$355.8K
$22.3M
Q1 25
$282.9K
$26.0M
Q4 24
$-1.9M
$15.2M
Q3 24
$1.1M
$23.3M
Q2 24
$655.8K
$12.1M
Q1 24
$556.2K
$-14.6M
Gross Margin
CCEL
CCEL
NREF
NREF
Q4 25
77.9%
Q3 25
77.0%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
CCEL
CCEL
NREF
NREF
Q4 25
-50.6%
Q3 25
24.3%
Q2 25
18.8%
Q1 25
13.3%
Q4 24
-1.5%
Q3 24
17.2%
Q2 24
17.3%
Q1 24
10.5%
Net Margin
CCEL
CCEL
NREF
NREF
Q4 25
-48.7%
216.6%
Q3 25
9.6%
407.0%
Q2 25
4.5%
184.5%
Q1 25
3.5%
225.6%
Q4 24
-23.2%
69.9%
Q3 24
13.0%
186.4%
Q2 24
8.2%
179.7%
Q1 24
7.1%
114.3%
EPS (diluted)
CCEL
CCEL
NREF
NREF
Q4 25
$-0.46
$0.47
Q3 25
$0.09
$1.14
Q2 25
$0.04
$0.54
Q1 25
$0.03
$0.70
Q4 24
$-0.23
$0.71
Q3 24
$0.13
$0.74
Q2 24
$0.08
$0.40
Q1 24
$0.07
$-0.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
NREF
NREF
Cash + ST InvestmentsLiquidity on hand
$3.3M
$31.1M
Total DebtLower is stronger
$8.4M
$771.2M
Stockholders' EquityBook value
$-18.6M
$388.0M
Total Assets
$61.7M
$5.3B
Debt / EquityLower = less leverage
1.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
NREF
NREF
Q4 25
$3.3M
$31.1M
Q3 25
$3.2M
$17.9M
Q2 25
$4.4M
$9.1M
Q1 25
$3.5M
$19.2M
Q4 24
$3.5M
$3.9M
Q3 24
$2.1M
$34.7M
Q2 24
$1.5M
$4.3M
Q1 24
$979.6K
$13.5M
Total Debt
CCEL
CCEL
NREF
NREF
Q4 25
$8.4M
$771.2M
Q3 25
$8.4M
$720.9M
Q2 25
$8.4M
$815.6M
Q1 25
$8.5M
$831.5M
Q4 24
$8.5M
$799.3M
Q3 24
$8.5M
$815.5M
Q2 24
$8.5M
$861.0M
Q1 24
$8.6M
$843.3M
Stockholders' Equity
CCEL
CCEL
NREF
NREF
Q4 25
$-18.6M
$388.0M
Q3 25
$-14.8M
$375.4M
Q2 25
$-15.6M
$348.2M
Q1 25
$-14.7M
$343.7M
Q4 24
$-13.2M
$336.5M
Q3 24
$-9.6M
$335.8M
Q2 24
$-10.7M
$327.5M
Q1 24
$-10.3M
$327.1M
Total Assets
CCEL
CCEL
NREF
NREF
Q4 25
$61.7M
$5.3B
Q3 25
$63.2M
$5.3B
Q2 25
$64.4M
$5.4B
Q1 25
$64.4M
$5.4B
Q4 24
$64.7M
$5.4B
Q3 24
$62.9M
$5.7B
Q2 24
$62.6M
$6.6B
Q1 24
$61.7M
$7.1B
Debt / Equity
CCEL
CCEL
NREF
NREF
Q4 25
1.99×
Q3 25
1.92×
Q2 25
2.34×
Q1 25
2.42×
Q4 24
2.38×
Q3 24
2.43×
Q2 24
2.63×
Q1 24
2.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
NREF
NREF
Operating Cash FlowLast quarter
$1.3M
$-4.5M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
-0.19×
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
NREF
NREF
Q4 25
$1.3M
$-4.5M
Q3 25
$2.5M
$8.1M
Q2 25
$707.0K
$3.3M
Q1 25
$954.1K
$16.0M
Q4 24
$2.2M
$4.4M
Q3 24
$2.4M
$14.7M
Q2 24
$1.8M
$-7.5M
Q1 24
$-356.9K
$17.7M
Free Cash Flow
CCEL
CCEL
NREF
NREF
Q4 25
$1.2M
Q3 25
$2.5M
Q2 25
$644.6K
Q1 25
$892.0K
Q4 24
$2.1M
Q3 24
$2.3M
Q2 24
$21.5K
Q1 24
$-814.6K
FCF Margin
CCEL
CCEL
NREF
NREF
Q4 25
15.5%
Q3 25
31.9%
Q2 25
8.1%
Q1 25
11.2%
Q4 24
26.8%
Q3 24
27.9%
Q2 24
0.3%
Q1 24
-10.4%
Capex Intensity
CCEL
CCEL
NREF
NREF
Q4 25
0.9%
Q3 25
0.5%
Q2 25
0.8%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
2.3%
Q2 24
21.8%
Q1 24
5.8%
Cash Conversion
CCEL
CCEL
NREF
NREF
Q4 25
-0.19×
Q3 25
3.38×
0.16×
Q2 25
1.99×
0.15×
Q1 25
3.37×
0.62×
Q4 24
0.29×
Q3 24
2.32×
0.63×
Q2 24
2.70×
-0.62×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons